跳至主要内容
临床试验/EUCTR2022-001795-34-DE
EUCTR2022-001795-34-DE进行中(未招募)1 期

A prospective randomized single blind multicenter phase II study of organ perfusion with Custodiol-N compared with Custodiol in heart transplantation in children

Dr. Franz Köhler Chemie GmbH0 个研究点目标入组 15 人开始时间: 2022年9月15日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patient criteria:
  • - Age from birth to less than18 years
  • - Recipients awaiting their first transplant
  • - Ability of the patients and/ or their legal guardians to understand character and individual consequences of the clinical trial
  • - written informed consent of the patients and/ or their legal guardians (must be available before enrolment in the study)
  • - Patient listed on the waiting list for heart transplantation
  • Donor criteria:
  • - deceased donors should fulfil the standard criteria for organ donation (SCD)
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 15
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Patient criteria:
  • - Patients who have participated within 30 days or are still participating in any other interventional studies
  • - history of severe organic disease other than concerning the heart
  • - history/demonstration of HIV antibodies or AIDS
  • - multiorgan transplantation
  • - machine-perfused organ
  • - the explantation team is affiliated to another clinic than transplantation team
  • -Failing Fontan patients
  • -Pregnancy and lactation

研究者

相似试验